Home Zacks Gives Neutral Rating to Teva Pharmaceutical Industries Ltd
 

Keywords :   


Zacks Gives Neutral Rating to Teva Pharmaceutical Industries Ltd

2013-02-12 11:19:20| Biotech - Topix.net

The firm currently has a $41.00 target price on the stock. Zacks' analyst wrote, "Teva's fourth quarter earnings of $1.32 per American Depositary Share were a penny short of the Zacks Consensus Estimate and 17% below the year-ago earnings.

Tags: rating ltd industries neutral

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.11New2DS LL ×AC
25.11Playstation vita Wi-Fi
25.11 UGC
25.11
25.11Soomloom
25.11BMW Z4 M coupe 2009 PMA
25.11 DVD-BOX
25.11(mizuki) ()
More »